Clinical trial

Cohort Study of Patients With HER2-negative MBC and BRCA 1/2 Pathogenic Mutation

NCT04368442

StatusUNKNOWN

Study typeOBSERVATIONAL

Start date2019-10-17

PhaseN/A

Study timeline

Study start (actual)2019-10-17Date precision: day

Registry last updated2020-04-29

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancer Metastaticunresolved

Interventions

Sponsors & collaborators

Samsung Medical Centerlead sponsor

Mapped research locations

SeoulSouth Korea1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04368442 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.